"Tobacco dependence treatment makes no sense because"⋯: Rebuttal of commonly-heard arguments against providing tobacco dependence treatment in the hospital setting

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Balmford, James ^a   Leifert, Jens A ^b   Jaehne, Andreas ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Breisgauklinik ^*  (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Hospital; Tobacco control; Tobacco dependence treatment

Indexed keywords

NICOTINE GUM;

COMPLICATION; GERMANY; HUMAN; PROCEDURES; PSYCHOLOGY; SMOKING CESSATION; TOBACCO USE DISORDER; UNIVERSITY HOSPITAL; WITHDRAWAL SYNDROME;

GERMANY; HOSPITALS, UNIVERSITY; HUMANS; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84964314954     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1182     Document Type: Article

References (67)

1. World Health Organization: WHO Report on the Global Tobacco Epidemic. Geneva: World Health Organization; 2008.
2. Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 2004, 328:1519.
3. U.S. Department of Health and Human Services: The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA, US: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 2004. Office of Smoking and Health.
4. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE: The effects of a smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann Intern Med 2005, 142:233-239.
5. Van Domburg RT, Op Reimer WS, Hoeks SE, Kappetein AP, Bogers AJ: Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30-year follow-up study. Am Heart J 2008, 156:473-476.
6. Fiore MC, Goplerud E, Schroeder SA: The Joint Commission's new tobacco-cessation measures: will hospitals do the right thing? N Engl J Med 2012, 10:1056.
7. Kotseva K, Wood D, De Backer G, Pyorala K, Keil U: EUROPASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009, 16:121-137.
8. Rupp A, Neudert M, Hetzel M: Smoking cessation programmes at hospitals with departments for lung diseases. Dtsch Med Wochenschr 2010, 135:501-506.
9. Raupach T, Merker J, Hasenfuß G, Andreas S, Pipe A: Knowledge gaps about smoking cessation in hospitalized patients and their doctors. Eur J Cardiovasc Prev Rehabil 2011, 18:334-341.
10. Raupach T, Strobel L, Beard E, Krampe H, Anders S, West R: German medical students' beliefs about the effectiveness of different methods of stopping smoking. Nicotine Tob Res 2013, 15:1892-1901.
11. Fong GT, Hammond D, Laux FL, Zanna MP, Cummings KM, Borland R, Ross H: The near-universal experience of regret among smokers in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Nicotine Tob Res 2004, 6(Suppl 3):S341-S351.
12. Mullins R, Borland R: Do smokers want to quit? Aust N Z J Public Health 1996, 20:426-427.
13. Borland R, Partos TR, Yong H-H, Cummings KM, Hyland A: How much unsuccessful quitting activity is going on among adult smokers? Data from the International tobacco control four country cohort survey. Addiction 2012, 107:673-682.
14. Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP: Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000, 18:305-311.
15. Hughes JR, Keely J, Naud S: Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99:29-38.
16. Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP: Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health 2008, 98:317-322.
17. Yong H-H, Borland R, Siahpush M: Quitting-related beliefs, intentions, and motivations of older smokers in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Addict Behav 2005, 30:777-788.
18. Hyland A, Borland R, Li Q, Yong H-H, McNeill A, Fong GT, O'Connor RJ, Cummings KM: Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006, 15:iii83-iii94.
19. Balmford J, Borland R: What does it mean to want to quit? Drug Alcohol Rev 2008, 2008(27):21-27.
20. Vangeli E, Stapleton J, Smit ES, Borland R, West R: Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011, 106:2110-2121.
21. Borland R, Yong H-H, Balmford J, Cooper J, Cummings KM, O'Connor RJ, McNeill A, Zanna MP, Fong GT: Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four Country project. Nicotine Tob Res 2010, 12(Suppl 1):S4-S11.
22. West R, McEwen A, Bolling K, Owen L: Smoking cessation and smoking patterns in the general population: a 1-year follow-up. Addiction 2001, 96:891-902.
23. Kasza KA, Hyland AJ, Borland R, McNeill AD, Bansal-Travers M, Fix BV, Hammond D, Fong GR, Cummings KM: Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 2013, 108:193-202.
24. Hammond D, McDonald PW, Fong GT, Borland R: Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction 2004, 99:1042-1048.
25. Borland R, Li L, Driezen P, Wilson N, Hammond D, Thompson ME, Fong GT, Mons U, Willemsen MC, McNeill A, Thrasher JF, Cummings KM: Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction 2012, 107:197-205.
26. Chapman S, Liberman J: Ensuring smokers are adequately informed: reflections on consumer rights, manufacturer responsibilities, and policy implications. Tob Control 2005, 14(Suppl II):ii8-ii13.
27. Cummins SE, Bailey L, Campbell S, Koon-Kirby C, Zhu S-H: Tobacco cessation quitlines in North America: a descriptive study. Tob Control 2007, 16(Suppl I):i9-i15.
28. Murray RL, Coleman T, Antoniak M, Stocks J, Fergus A, Britton J, Lewis SA: The effect of proactively identifying smokers and offering smoking cessation support in primary care populations: a cluster-randomized trial. Addiction 2008, 103:998-1006.
29. Tzelepis F, Paul CL, Walsh RA, Wiggers J, Duncan SL, Knight J: Active telephone recruitment to quitline services: are nonvolunteer smokers receptive to cessation support? Nicotine Tob Res 2009, 11:1205-1215.
30. Balmford J, Borland R, Benda P, Howard S: Factors associated with use of automated smoking cessation interventions: findings from the eQuit study. Health Educ Res 2013, 28:288-299.
31. Rigotti NA, Bitton A, Kelley JK, Hoeppner BB, Levy DE, Mort E: Offering population-based tobacco treatment in a healthcare setting: a randomized controlled trial. Am J Prev Med 2011, 41:498-503.
32. Balmford J, Leifert JA, Schulz C, Elze M, Jaehne A: Implementation and effectiveness of a hospital smoking cessation service in Germany. Patient Educ Couns 2014, 94:103-109.
33. Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T: It is possible to help smokers in early motivational stages to quit: the Inter99 study. Prev Med 2005, 40:278-284.
34. Lai DTC, Cahill K, Qin Y, Tang JL: Motivational interviewing for smoking cessation (Review). Cochrane Database Syst Rev 2010, 1:CD006936.
35. Raupach T, Falk J, Vangeli E, Schiekirka S, Rustler C, Grassi MC, Pipe A, West R: Structured smoking cessation training for health professionals on cardiology wards: a prospective study. Eur J Prev Cardiol 2012, 21(7):915-922.
36. Hughes JR: Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007, 9:315-327.
37. West R, Hajek P, Foulds J, Nilsson F, Burrows S, Meadows A: A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology (Berl) 2000, 149:198-202.
38. International Agency for Research on Cancer: Tobacco smoke and involuntary smoking. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Volume 83. Lyon: International Agency for Research on Cancer; 2004.
39. Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO: Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis 2010, 8:8.
40. Hubbard R, Lewis S, Smith C, Godfrey C, Smeeth L, Farrington P, Britton J: Use of nicotine replacement therapy and the risk of acute myocardial infarction and death. Tob Control 2005, 14:416-421.
41. Joseph AM, Fu SS: Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Prog Cardiovasc Dis 2003, 45:429-441.
42. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J: Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011, 106:52-61.
43. Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007, 1:CD000031.
44. Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012, 4:CD006103.
45. Singh S, Loke YK, Spangler JG, Furberg CD: Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. Can Med Assoc J 2011, 183:1359-1366.
46. Food and Drug Administration: Public Health Advisory: FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor PatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm169986.htm. Accessed 18 December 2012.
47. Prochaska JJ, Hilton JF: Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. Br Med J 2012, 344:e2856.
48. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME: Treating tobacco use and dependence: 2008 update. In US Department of Health and Human Services 2008, Public Health Service.
49. Pipe A, Sorensen M, Reid R: Physician smoking status, attitudes toward smoking, and cessation advice to patients: an international survey. Patient Educ Couns 2009, 74:118-123.
50. Kawahara M, Ushijima S, Kamimori T, Kodama N, Ogawara M, Matsui K, Masuda N, Takada M, Sobue T, Furuse K: Second primary tumors in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer 1998, 78:409-412.
51. Videtic GMM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Yu EW: Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003, 21:1544-1549.
52. Jensen K, Jensen AB, Grau C: Smoking has a negative impact upon health related quality of life after treatment for head and neck cancer. Oral Oncol 2007, 43:187-192.
53. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, Mandrekar SJ, Yang P: Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer 2012, 48:1593-1601.
54. Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, Moncure AC, Grillo HC, Mathisen DJ: Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg 1999, 118:702-709.
55. Cox LS, Africano NL, Tercyak KP, Taylor KL: Nicotine dependence treatment for patients with cancer: Review and recommendations. Cancer 2003, 98:632-644.
56. Levy DT, Graham AL, Mabry PL, Abrams DB, Orleans CT: Modeling the impact of smoking cessation treatment policies on quit rates. Am J Prev Med 2010, 38(3 Suppl):S364-S372.
57. Zevin S, Benowitz NL: Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999, 36:425-438.
58. Rigotti NA: Strategies to help a smoker who is struggling to quit. J Am Med Assoc 2012, 308:1573-1580.
59. Chapman S, MacKenzie R: The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 2010, 7(2):e1000216.
60. Wolfenden L, Campbell E, Walsh RA, Wiggers J: Smoking cessation interventions for in-patients: a selective review with recommendations for hospital-based health professionals. Drug Alcohol Rev 2003, 22:437-452.
61. Rigotti N, Clair C, Munafò MR, Stead LF: Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012, 5:CD001837.
62. Barendregt JJ, Bonneux L, Van der Maas PJ: The health care costs of smoking. N Engl J Med 1997, 337:1052-1057.
63. Rasmussen SR, Prescott E, Sorensen TIA, Sogaard J: The total lifetime health cost savings of smoking cessation to society. Eur J Public Health 2005, 15:601-606.
64. Ross H: Critique of the Philip Morris study of the cost of smoking in the Czech Republic. Nicotine Tob Res 2004, 6:181-189.
65. Warner K, Fulton G: Importance of tobacco to a country's economy: an appraisal of the tobacco industry's economic argument. Tob Control 1995, 4:180-183.
66. Lewis KE, Durgan L, Edwards VM, Dixon H, Whitehead C, Sykes RN: Can smokers switch from a hospital-based to a community-based stop smoking service? An open-label, randomized trial comparing three referral schemes. Nicotine Tob Res 2009, 11:756-764.
67. Cummins S, Zhu SH, Garnst A, Kirby C, Brandstein K, Klonoff-Cohen H, Chaplin E, Morris T, Seymann J, Lee J: Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial. Trials 2012, 13:128.